Gamma-glutamyl transferase as a biomarker for cardiovascular disease risk stratification
This study demonstrates that elevated gamma-glutamyl transferase (GGT) levels are significantly associated with increased risks of both prevalent and incident cardiovascular disease across large cohorts, supporting its utility as a valuable biomarker for risk stratification even in traditionally low-risk populations.